Prism Medico & Pharmacy Limited held a Board of Directors meeting on May 05, 2026, at its registered office located at Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh. The board approved the allotment of equity shares and convertible warrants on a preferential basis, a development rooted in shareholder approval obtained at an earlier Extra-ordinary General Meeting.

Preferential Allotment Details

The board approved the allotment of 75,00,000 (Seventy Five Lacs) equity shares and 50,00,000 (Fifty Lacs) convertible warrants. Both the equity shares and the convertible warrants carry a face value of ₹10/- each and were issued at an issue price of ₹10/- per unit. The following table summarises the key parameters of the allotment:

Regulatory and Shareholder Approvals

The allotment was carried out in accordance with and pursuant to a special resolution passed by the members of the company at their Extra-ordinary General Meeting held on March 20, 2026. Additionally, In-Principle Approval was received from BSE Ltd, the stock exchange where the shares of the company are listed, on March 25, 2026. The details of the allottees have been enclosed with the exchange communication.

Board Authorisation

The outcome of the board meeting was communicated to the exchanges by Director Davender Singh (DIN: 09447213). The disclosure was made to both BSE Limited and the Metropolitan Stock Exchange of India Limited (MSEI) as part of the company's regulatory obligations under Regulation 30.

Prism medico & pharmacy Limited has filed its quarterly compliance certificate with BSE Limited and Metropolitan Stock Exchange of India Limited (MSEI) for the quarter ended March 31, 2026. The submission fulfills regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Submission

The company submitted the confirmation certificate as mandated by Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. The certificate was issued by Purva Sharegistry (India) Pvt. Ltd., which serves as the company's Registrar and Share Transfer Agent (RTA).

Share Dematerialization Activity

The detailed report covering the period from January 1, 2026 to March 31, 2026 shows no dematerialization activity during the quarter. The certificate confirms that no security certificates were received from depository participants for dematerialization during this period.

RTA Confirmation

Purva Sharegistry (India) Pvt. Ltd., a SEBI registered Category 1 Registrar and Share Transfer Agent, confirmed compliance with all regulatory requirements. The RTA verified that securities received for dematerialization are processed within prescribed timelines and that proper procedures are followed for certificate handling and member register updates.

Company Information

Prism Medico and Pharmacy Limited is registered in Himachal Pradesh with its office located at Suketi Road, Kala Amb, Sirmaur. The company's shares are listed on both BSE Limited and Metropolitan Stock Exchange of India Limited. Director Davender Singh signed the compliance submission on behalf of the company.